Investment
Features
FeesSafety
Academy
More
Pluang+

Nova Minerals begins construction of antimony plant in Alaska, targeting 2027 production with US defense support.

Market News
08 Oct 2026
GlobeNewsWire
View Source
Bullish
Nova Minerals begins construction of antimony plant in Alaska, targeting 2027 production with US defense support.

Nova Minerals has received all key equipment for its antimony processing and refinery plant at Port MacKenzie, Alaska, enabling construction to start soon pending final permits. This project, backed by a $43.4 million U.S. Department of War award, aims to establish a secure domestic antimony supply chain critical for defense and advanced technologies. The 2026 field season at the Estelle project concluded with drilling and infrastructure progress, supporting future resource development. Nova expects first antimony production in 2027 as construction and analysis continue through the winter months.

Nova Minerals' antimony project progress is context for readers following Basic Materials. Of 38 priced Basic Materials-sector US stocks tradable on Pluang, 16 rose and 21 fell today. BHP was priced at USD 84.00 with a 1-day change of -1.43% and 100% buy order activity, Rio Tinto (ADR) at USD 91.90 with a -1.35% change, and Harmony Gold Mining Co. at USD 16.28 with a -1.27% change and 100% buy order activity. This data is as of Oct 08, 2026 17:11 WIB.

More News

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...

Market News
Bullish
43 minutes ago
Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...

Market News
Bullish
1 hour ago
Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...

Market News
Bearish
2 hours ago
Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...

Market News
Bullish
2 hours ago
MBody AI files two new patents to enhance its AI platform for enterprise robotics management.

MBody AI files two new patents to enhance its AI platform for enterprise robotics management.

MBody AI has filed two new patent applications to protect its AI orchestration platform, Orchestrator, which integrates autonomous equipment from multiple robotics manufacturers for enterprise customers. One patent focuses on AI architecture for mana...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App